Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial tenecteplase after incomplete reperfusion following mechanical thrombectomy for acute ischemic stroke
NL-OMON59008Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tenecteplase in ischemic stroke (2 arms), sponsored by Insel Gruppe. Primary endpoint: Early and late reperfusion. Started May 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON59008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59008.